Lantheus Holdings has finalized the sale of its SPECT business to SHINE Technologies, including diagnostic agents and manufacturing facilities. This allows Lantheus to focus on its portfolio of PET radiodiagnostics and microbubbles, as well as advancing its radiopharmaceutical pipeline. The agreement marks a strategic shift for Lantheus in the healthcare industry.

Read more at Yahoo Finance: Lantheus closes SPECT business sale to SHINE Technologies